Qube Research & Technologies (QRT)
LLY icon

Qube Research & Technologies (QRT)’s Eli Lilly LLY Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$91M Sell
75,900
-16,900
-18% -$17.3M 0.08% 313
2026
Q1 		$85.4M Sell
92,800
-46,900
-34% -$47.5M 0.09% 256
2025
Q4 		$150M Sell
139,700
-2,300
-2% -$2.2M 0.15% 131
2025
Q3 		$108M Buy
142,000
+54,700
+63% +$40.7M 0.11% 223
2025
Q2 		$68.1M Buy
87,300
+35,500
+69% +$27.6M 0.07% 370
2025
Q1 		$42.8M Buy
51,800
+1,700
+3% +$1.41M 0.05% 463
2024
Q4 		$38.7M Sell
50,100
-8,000
-14% -$6.62M 0.05% 469
2024
Q3 		$51.5M Buy
58,100
+34,600
+147% +$31.1M 0.08% 341
2024
Q2 		$21.3M Buy
23,500
+12,600
+116% +$10.1M 0.03% 586
2024
Q1 		$8.48M Sell
10,900
-11,200
-51% -$7.97M 0.01% 938
2023
Q4 		$12.9M Buy
+22,100
New +$12.9M 0.03% 644
2022
Q4 		– Sell
-30,000
Closed -$9.7M – 2774
2022
Q3 		$9.7M Buy
+30,000
New +$9.51M 0.06% 424

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Qube Research & Technologies (QRT)'s LLY Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Eli Lilly (LLY) stake by 52% in Q2 2026, selling an estimated $377M and leaving 346,498 shares worth $416M. The position accounts for 0.39% of the portfolio, ranked #30.

Qube Research & Technologies (QRT) first reported a position in LLY in Q1 2018 and has held it in 28 quarters since. The position peaked at $658M in Q1 2026. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Qube Research & Technologies (QRT) held 346,498 shares of Eli Lilly worth $416M as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 368,584 Eli Lilly shares in Q2 2026, an estimated $377M.
  • Eli Lilly made up 0.39% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #30 holding.
  • Qube Research & Technologies (QRT) first reported a position in Eli Lilly in Q1 2018 and has held it in 28 quarters since.
  • Qube Research & Technologies (QRT)'s Eli Lilly position peaked at $658M in Q1 2026.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.